患者对心血管疾病风险沟通工具的有用性和影响的看法:定性分析
Anders Elkær Jensen1, Jens Søndergaard2, Niels Kristian Kjær2
1Research Unit of General Practice, Department of Public Health, University of Southern Denmark, Campusvej 55, Odense, 5230, Denmark. anejensen@health.sdu.dk.
BMC primary care
|February 3, 2024
概括
使用心血管风险工具治疗高血压的患者获得了洞察力,但没有关注. 易于使用的技术和支持性的全科医生是治疗坚持和有效的风险沟通的关键.
科学领域:
- 心血管疾病风险沟通 心血管疾病风险沟通
- 患者的坚持 患者的坚持
- 医疗信息学 医疗信息学
背景情况:
- 对风险沟通的理解不足可能导致治疗不充分遵守.
- 高血压管理是预防心血管疾病的关键领域.
- 调查患者对风险沟通工具的看法对于改善健康结果至关重要.
研究的目的:
- 评估患者对视觉和动态心血管风险沟通工具的看法.
- 了解风险沟通干预如何影响高血压患者的治疗坚持.
- 确定影响数字健康工具在控制心血管风险方面的有效性因素.
主要方法:
- 与患有高血压的患者进行了半结构化的个人访谈.
- 该研究利用了一般实践中随机对照试验的数据.
- 使用马尔特鲁德的系统文本凝结方法进行了定性数据分析.
主要成果:
- 易于使用和易于访问的IT设置对遵守产生了积极影响;故障产生了负面影响.
- 这项干预措施增加了患者对心血管疾病风险的自我报告洞察力,但并没有引起关注.
- 卫生专业人员的参与和对全科医生的信任显著影响了患者的坚持和对该工具有用性的看法.
结论:
- 虽然患者获得了对心血管风险的洞察力,但没有报告增加的担忧,这凸显了风险感知的复杂性.
- 患者的动机和风险感知对于治疗坚持至关重要,这强调了需要量身定制的沟通策略.
- 一般医生在成功实施和患者接受新的健康沟通工具方面发挥着关键作用.
更多相关视频
相关概念视频
Assessment of the Cardiovascular System I: Subjective Data
343
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
343
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
128
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
128
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.8K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.8K
Hazard Ratio
124
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
124
Heart Failure Drugs: β-Blockers
340
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
340
Role of Communication in the Nursing Process II: Planning and Implementation
1.8K
Several factors are considered while creating a patient's care plan. Motivation is a factor in improving communication, and patients often require encouragement to try different approaches involving significant change. It is essential to involve the patient and family in decisions about the plan of care to determine whether the suggested methods are acceptable. Consider meeting critical comfort and safety needs before introducing new communication methods and techniques. Allow adequate time...
1.8K


